1.cGAS: Its Canonical and Non-canonical Functions
Wen-Xian ZHENG ; Meng-Jie XIONG ; Shu-Ting JIA ; Ruo-Yu ZHOU
Progress in Biochemistry and Biophysics 2026;53(5):1279-1296
Cyclic GMP-AMP synthase (cGAS), a pivotal molecule in innate immunity, has emerged as a keypoint in interdisciplinary research at the intersection of basic immunology and tumor biology. As a cytosolic nucleic acid sensor, cGAS is primarily characterized by its capacity to recognize double-stranded DNA (dsDNA) in the cytosol. Upon binding to dsDNA, cGAS undergoes a conformational change that promotes its dimerization and subsequent enzymatic activation. Once activated, it catalyzes the synthesis of the second messenger 2',3'-cGAMP from ATP and GTP. cGAMP then binds to the adaptor protein STING, which resides on the endoplasmic reticulum (ER) membrane. The binding process triggers STING to traffic from the ER to the Golgi apparatus, where it is phosphorylated by the kinase TBK1. Phosphorylated STING serves as a docking site for the transcription factor IRF3, facilitating its phosphorylation by TBK1. Once phosphorylated, IRF3 forms dimers and translocates to the nucleus, where it drives the expression of type I interferons and pro-inflammatory cytokines, initiating a potent antimicrobial state. The DNA-sensing mechanism of cGAS is inherently non-selective regarding the origin of its ligand. It readily detects exogenous DNA from invading pathogens, thereby playing an indispensable role in host defense against microbial infections. However, this same mechanism also enables cGAS to recognize self-DNA that leaks from the nucleus or mitochondria into the cytosol under various cellular stress conditions. While critical for immunity, the recognition of self-dsDNA by cGAS can disrupt cellular homeostasis and trigger aberrant inflammatory responses. The loss of self-tolerance can precipitate or exacerbate the pathogenesis of autoimmune disorders such as systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome (AGS), highlighting the dual role of cGAS as both a sentinel for infection and a potential driver of autoimmune pathology. Notably, the subcellular localization of cGAS is not still. Increasing recent researches have revealed that cGAS is also abundant within the nucleus, challenging the traditional view of it solely as a cytosolic nucleic acid sensor. Within the nucleus, cGAS exhibits non-canonical functions that are distinct from its canonical immunological role. First, cGAS exists in a state of stringent immunological silence in the nucleus, with mechanisms involving its competitive binding to histones and its post-translational modifications which block the activation of cGAS enzymatic activity, thus, effectively preventing it from mounting an autoimmune attack on genomic DNA. Second, cGAS plays a critical role in maintaining genomic stability. Upon DNA damage, cGAS is rapidly recruited to the lesion site and participates in the DNA damage repair process. Moreover, under conditions of DNA replication stress, cGAS contributes to the stabilization of replication forks, preventing the cell from entering a state of uncontrolled hyper-replication. Consequently, in light of the dual role of cGAS in both immune regulation and tumor development, the development of small-molecule drugs targeting cGAS holds significant therapeutic promise. This review summarizes the structural characteristics of cGAS and its canonical function as a pattern recognition receptor in the cytosol, including the types of pathogens it recognizes and the autoimmune responses resulting from erroneous recognition of self-DNA. It then focuses on its emerging non-canonical functions within the nucleus, detailing its nucleocytoplasmic shuttling, the mechanisms underlying its nuclear immune quiescence, and its role in mediating DNA damage repair and replication fork stabilization. Finally, the review discusses the progress and application prospects of small-molecule drugs targeting cGAS for the treatment of autoimmune diseases and cancer.
2.Analysis on Construction of Whole-course Management Model for Panvascular Diseases
Shuyuan LIU ; Jie WANG ; Jun LI ; Xingjiang XIONG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(1):12-22
Panvascular diseases are systemic diseases with atherosclerosis as the pathological core, involving multiple vascular beds and target organs throughout the body. Due to their wide range and complexity, the traditional single-discipline prevention and treatment model struggles to meet the needs of systematic management, while clinical diagnosis often remains one-sided and insufficient, leading to delayed treatment. Literature reviews show that panvascular diseases involve a wide range of lesion sites, numerous influencing factors, and are prone to endangering life and health. It is urgent to construct a comprehensive and whole-course prevention and treatment management system, with vascular health as the goal and patients as the core. First, early screening and risk assessment should be conducted for high-risk groups. In terms of treatment decisions for patients, multi-disciplinary collaboration is needed to establish a scientific and standardized prevention and treatment path. Second, it is important to attach great importance to a people-centered approach, enhance patients' familiarity with the disease through cognitive intervention, and shift from passive treatment to active health care. Thirdly, it is needed to leverage the advantages of modern science and technology, promote the deep integration of artificial intelligence innovations and modern medicine, and help traditional diagnosis and treatment plans evolve towards precision, intelligence, and personalization. This will open up new paths for the modernization of the whole-course management of pan-vascular diseases. Fourth, efforts should be made to continue to carry forward and innovate the characteristics of traditional Chinese medicine, adhere to equal emphasis on modern and traditional medicine, promote complementary advantages and coordinated development of Chinese and Western medicine, and form a unique Chinese model for the whole-course management of panvascular diseases. Fifth, through the reintegration and redistribution of government, medical insurance, and medical resources, comprehensive talents in the broad vascular disciplines should be cultivated and an efficient hierarchical management model established, providing reference and guidance for the whole-course management of comprehensive diseases in the future.
3.Targeting M1/M2 Macrophage Polarization Balance by Traditional Chinese Medicine in Treatment of Bronchial Asthma: A Review
Jie LIU ; Yasheng DENG ; Weiping YIN ; Lei XIONG ; Na WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(10):308-317
Bronchial asthma (BA) is a common chronic inflammatory airway disease characterized by airway hyperresponsiveness and reversible airflow limitation. Lung macrophages (LMs), as important effector cells of the innate immune system, play an important role in recognizing and engulfing pathogens, clearing harmful particles, and regulating immune responses. LMs can be polarized to M1 (pro-inflammatory) or M2 (anti-inflammatory) in different immune environments and participate in promoting or inhibiting inflammatory response, as well as lung parenchyma injury and repair (airway remodeling), playing a key role in the BA occurrence and development. Regulating the polarization balance of macrophages can not only inhibit the inflammatory response in the airway and reduce airway hyperresponsiveness, but also improve airway remodeling and immune regulation, reduce airway mucus secretion, and alleviate the clinical BA symptoms. Traditional Chinese medicine and its active ingredients, especially polysaccharides and saponins, can regulate the polarization balance of M1/M2 macrophages. Traditional Chinese medicine compounds can balance the secretion of anti-inflammatory and pro-inflammatory factors by staging treatment and targeting the polarization state of M1/M2 macrophages, inhibit inflammatory response in the airway, reduce airway remodeling, and improve the BA symptoms. This paper summarized the research progress on the regulation of M1/M2 macrophage polarization by traditional Chinese medicine and its active ingredients, aiming to provide scientific evidence for the precise targeted therapy of BA.
4.Targeting M1/M2 Macrophage Polarization Balance by Traditional Chinese Medicine in Treatment of Bronchial Asthma: A Review
Jie LIU ; Yasheng DENG ; Weiping YIN ; Lei XIONG ; Na WANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(10):308-317
Bronchial asthma (BA) is a common chronic inflammatory airway disease characterized by airway hyperresponsiveness and reversible airflow limitation. Lung macrophages (LMs), as important effector cells of the innate immune system, play an important role in recognizing and engulfing pathogens, clearing harmful particles, and regulating immune responses. LMs can be polarized to M1 (pro-inflammatory) or M2 (anti-inflammatory) in different immune environments and participate in promoting or inhibiting inflammatory response, as well as lung parenchyma injury and repair (airway remodeling), playing a key role in the BA occurrence and development. Regulating the polarization balance of macrophages can not only inhibit the inflammatory response in the airway and reduce airway hyperresponsiveness, but also improve airway remodeling and immune regulation, reduce airway mucus secretion, and alleviate the clinical BA symptoms. Traditional Chinese medicine and its active ingredients, especially polysaccharides and saponins, can regulate the polarization balance of M1/M2 macrophages. Traditional Chinese medicine compounds can balance the secretion of anti-inflammatory and pro-inflammatory factors by staging treatment and targeting the polarization state of M1/M2 macrophages, inhibit inflammatory response in the airway, reduce airway remodeling, and improve the BA symptoms. This paper summarized the research progress on the regulation of M1/M2 macrophage polarization by traditional Chinese medicine and its active ingredients, aiming to provide scientific evidence for the precise targeted therapy of BA.
5.cGAS: Its Canonical and Non-canonical Functions
Wen-Xian ZHENG ; Meng-Jie XIONG ; Shu-Ting JIA ; Ruo-Yu ZHOU
Progress in Biochemistry and Biophysics 2026;53(5):1279-1296
Cyclic GMP-AMP synthase (cGAS), a pivotal molecule in innate immunity, has emerged as a keypoint in interdisciplinary research at the intersection of basic immunology and tumor biology. As a cytosolic nucleic acid sensor, cGAS is primarily characterized by its capacity to recognize double-stranded DNA (dsDNA) in the cytosol. Upon binding to dsDNA, cGAS undergoes a conformational change that promotes its dimerization and subsequent enzymatic activation. Once activated, it catalyzes the synthesis of the second messenger 2',3'-cGAMP from ATP and GTP. cGAMP then binds to the adaptor protein STING, which resides on the endoplasmic reticulum (ER) membrane. The binding process triggers STING to traffic from the ER to the Golgi apparatus, where it is phosphorylated by the kinase TBK1. Phosphorylated STING serves as a docking site for the transcription factor IRF3, facilitating its phosphorylation by TBK1. Once phosphorylated, IRF3 forms dimers and translocates to the nucleus, where it drives the expression of type I interferons and pro-inflammatory cytokines, initiating a potent antimicrobial state. The DNA-sensing mechanism of cGAS is inherently non-selective regarding the origin of its ligand. It readily detects exogenous DNA from invading pathogens, thereby playing an indispensable role in host defense against microbial infections. However, this same mechanism also enables cGAS to recognize self-DNA that leaks from the nucleus or mitochondria into the cytosol under various cellular stress conditions. While critical for immunity, the recognition of self-dsDNA by cGAS can disrupt cellular homeostasis and trigger aberrant inflammatory responses. The loss of self-tolerance can precipitate or exacerbate the pathogenesis of autoimmune disorders such as systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome (AGS), highlighting the dual role of cGAS as both a sentinel for infection and a potential driver of autoimmune pathology. Notably, the subcellular localization of cGAS is not still. Increasing recent researches have revealed that cGAS is also abundant within the nucleus, challenging the traditional view of it solely as a cytosolic nucleic acid sensor. Within the nucleus, cGAS exhibits non-canonical functions that are distinct from its canonical immunological role. First, cGAS exists in a state of stringent immunological silence in the nucleus, with mechanisms involving its competitive binding to histones and its post-translational modifications which block the activation of cGAS enzymatic activity, thus, effectively preventing it from mounting an autoimmune attack on genomic DNA. Second, cGAS plays a critical role in maintaining genomic stability. Upon DNA damage, cGAS is rapidly recruited to the lesion site and participates in the DNA damage repair process. Moreover, under conditions of DNA replication stress, cGAS contributes to the stabilization of replication forks, preventing the cell from entering a state of uncontrolled hyper-replication. Consequently, in light of the dual role of cGAS in both immune regulation and tumor development, the development of small-molecule drugs targeting cGAS holds significant therapeutic promise. This review summarizes the structural characteristics of cGAS and its canonical function as a pattern recognition receptor in the cytosol, including the types of pathogens it recognizes and the autoimmune responses resulting from erroneous recognition of self-DNA. It then focuses on its emerging non-canonical functions within the nucleus, detailing its nucleocytoplasmic shuttling, the mechanisms underlying its nuclear immune quiescence, and its role in mediating DNA damage repair and replication fork stabilization. Finally, the review discusses the progress and application prospects of small-molecule drugs targeting cGAS for the treatment of autoimmune diseases and cancer.
6.Application of "balance-shaped sternal elevation device" in the subxiphoid uniportal video-assisted thoracoscopic surgery for anterior mediastinal masses resection
Jinlan ZHAO ; Weiyang CHEN ; Chunmei HE ; Yu XIONG ; Lei WANG ; Jie LI ; Lin LIN ; Yushang YANG ; Lin MA ; Longqi CHEN ; Dong TIAN
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(03):308-312
Objective To introduce an innovative technique, the "balance-shaped sternal elevation device" and its application in the subxiphoid uniportal video-assisted thoracoscopic surgery (VATS) for anterior mediastinal masses resection. Methods Patients who underwent single-port thoracoscopic assisted anterior mediastinal tumor resection through the xiphoid process at the Department of Thoracic Surgery, West China Hospital, Sichuan University from May to June 2024 were included, and their clinical data were analyzed. Results A total of 7 patients were included, with 3 males and 4 females, aged 28-72 years. The diameter of the tumor was 1.9-17.0 cm. The operation time was 62-308 min, intraoperative blood loss was 5-100 mL, postoperative chest drainage tube retention time was 0-9 days, pain score on the 7th day after surgery was 0-2 points, and postoperative hospital stay was 3-12 days. All patients underwent successful and complete resection of the masses and thymus, with favorable postoperative recovery. Conclusion The "balance-shaped sternal elevation device" effectively expands the retrosternal space, providing surgeons with satisfactory surgical views and operating space. This technique significantly enhances the efficacy and safety of minimally invasive surgery for anterior mediastinal masses, reduces trauma and postoperative pain, and accelerates patient recovery, demonstrating important clinical significance and application value.
7.Guideline for Adult Weight Management in China
Weiqing WANG ; Qin WAN ; Jianhua MA ; Guang WANG ; Yufan WANG ; Guixia WANG ; Yongquan SHI ; Tingjun YE ; Xiaoguang SHI ; Jian KUANG ; Bo FENG ; Xiuyan FENG ; Guang NING ; Yiming MU ; Hongyu KUANG ; Xiaoping XING ; Chunli PIAO ; Xingbo CHENG ; Zhifeng CHENG ; Yufang BI ; Yan BI ; Wenshan LYU ; Dalong ZHU ; Cuiyan ZHU ; Wei ZHU ; Fei HUA ; Fei XIANG ; Shuang YAN ; Zilin SUN ; Yadong SUN ; Liqin SUN ; Luying SUN ; Li YAN ; Yanbing LI ; Hong LI ; Shu LI ; Ling LI ; Yiming LI ; Chenzhong LI ; Hua YANG ; Jinkui YANG ; Ling YANG ; Ying YANG ; Tao YANG ; Xiao YANG ; Xinhua XIAO ; Dan WU ; Jinsong KUANG ; Lanjie HE ; Wei GU ; Jie SHEN ; Yongfeng SONG ; Qiao ZHANG ; Hong ZHANG ; Yuwei ZHANG ; Junqing ZHANG ; Xianfeng ZHANG ; Miao ZHANG ; Yifei ZHANG ; Yingli LU ; Hong CHEN ; Li CHEN ; Bing CHEN ; Shihong CHEN ; Guiyan CHEN ; Haibing CHEN ; Lei CHEN ; Yanyan CHEN ; Genben CHEN ; Yikun ZHOU ; Xianghai ZHOU ; Qiang ZHOU ; Jiaqiang ZHOU ; Hongting ZHENG ; Zhongyan SHAN ; Jiajun ZHAO ; Dong ZHAO ; Ji HU ; Jiang HU ; Xinguo HOU ; Bimin SHI ; Tianpei HONG ; Mingxia YUAN ; Weibo XIA ; Xuejiang GU ; Yong XU ; Shuguang PANG ; Tianshu GAO ; Zuhua GAO ; Xiaohui GUO ; Hongyi CAO ; Mingfeng CAO ; Xiaopei CAO ; Jing MA ; Bin LU ; Zhen LIANG ; Jun LIANG ; Min LONG ; Yongde PENG ; Jin LU ; Hongyun LU ; Yan LU ; Chunping ZENG ; Binhong WEN ; Xueyong LOU ; Qingbo GUAN ; Lin LIAO ; Xin LIAO ; Ping XIONG ; Yaoming XUE
Chinese Journal of Endocrinology and Metabolism 2025;41(11):891-907
Body weight abnormalities, including overweight, obesity, and underweight, have become a dual public health challenge in Chinese adults: overweight and obesity lead to a variety of chronic complications, while underweight increases the risks of malnutrition, sarcopenia, and organ dysfunction. To systematically address these issues, multidisciplinary experts in endocrinology, sports science, nutrition, and psychiatry from various regions have held multiple weight management seminars. Based on the latest epidemiological data and clinical evidence, they expanded the guideline to include assessment and intervention strategies for underweight, in addition to the core content of obesity management. This guideline outlines the etiological mechanisms, evaluation methods, and multidimensional management strategies for overweight and obesity, covering key areas such as diagnosis and assessment, medical nutrition therapy, exercise prescription, pharmacological intervention, and psychological support. It is intended to provide a scientific and standardized approach to weight management across the adult population, aiming to curb the rising prevalence of obesity, mitigate complications associated with abnormal body weight, and improve nutritional status and overall quality of life.
8.Autophagy in different subtypes of breast cancer cells mediated by p-AMPK and its molecular mechanisms
Xin-jiao YANG ; Ru-yao HU ; Zhe XIONG ; Di ZOU ; Jie CAI ; Cong-long XIA ; Zhong-bin BAI ; Hong-ye ZHAO
Chinese Pharmacological Bulletin 2025;41(5):898-907
Aim To investigate the effect of p-AMPK activity on autophagy in different subtypes of MDA-MB-231(triple-negative breast cancer cells)and MCF-7(estrogen receptor-positive cells)and its regulatory mechanism.Methods MDA-MB-231 cells were trea-ted with EBSS,Baf-A1,and EBSS+Baf-A1 for four hours,and MCF-7 cells for eight hours.The effects of autophagy on cell proliferation and apoptosis were ob-served,mitochondrial morphology was examined,and the expression of autophagy markers LC3B,P62,LAMP1,TOM20,AMPK,p-AMPK,ULK1,and Bec-lin1/VPS34 proteins was detected.The autophagy pathway was validated by inhibiting AMPK activity.Results Breast cancer cells underwent autophagy af-ter starvation induction(EBSS),with inconsistent au-tophagy processes observed in different subtypes of breast cancer cells.Autophagy inhibited cell prolifera-tion.In MDA-MB-231 cells,autophagy led to an in-crease in p-AMPK levels and a decrease in ULK1 lev-els,initiating autophagy through p-AMPK activation of ULK1.In MCF-7 cells,both p-AMPK and ULK1 levels decreased after autophagy,suggesting that autophagy might not be mediated by p-AMPK activation.Conclu-sions MDA-MB-231 cells primarily initiate autophagy by directly activating ULK1 by p-AMPK,independent of the MTOR pathway.In MCF-7 cells autophagy might be triggered by inhibiting MTOR through AMPK activity or directly activating MTOR through other up-stream factors.Regulating p-AMPK activity based on the autophagy pathways in different cell subtypes could enable more precise targeting and treatment of different types of breast cancer.
9.Expert consensus on in-hospital transfer safety management for patients undergoing invasive mechanical ventilation
Jie XIONG ; Hong SUN ; Xiaoying WU ; Xin GUAN ; Liming LI ; Li ZHANG ; Yongming TIAN
Chinese Journal of Nursing 2025;60(17):2053-2056
Objective To establish an expert consensus on in-hospital transfer safety management for patients undergoing invasive mechanical ventilation,providing guidance for clinical medical teams to conduct standardized transfers,reduce transfer risks,and ensure patient safety.Methods Through systematic searching,screening,evaluation,and summary of evidence related to in-hospital transfer safety management for patients on invasive mechanical ventilation,we extracted recommendations to form a preliminary draft of the expert consensus.From July to October 2024,totally 2 rounds of expert consultations,and 2 rounds of expert reviews were conducted,and the content was refined and finalized based on expert feedback.Results The final consensus encompasses 9 aspects,including transfer assessment and decision-making,pre-transfer preparation of medical staff,pre-transfer patient preparation,pre-transfer equipment preparation,pre-transfer medication preparation,monitoring and intervention during transfer,emergency events and management,transfer handover and documentation,and post-transfer management.Conclusion This consensus demonstrates strong practicality and operability,offering professional guidance for enhancing the safety of in-hospital transfers for patients on invasive mechanical ventilation.
10.Characteristics and related factors of quality of life in college students
Hongyu SU ; Jie REN ; Nana XIONG ; Qi LIU
Chinese Mental Health Journal 2025;39(4):378-384
Objective:To assess the quality of life in college students and to explore its related factors.Met-hods:A sample of 1 423 college students were recruited and assessed with the short form Quality of Life Scale-12(SF-12),Patient Health Questionnaire-9(PHQ-9),Generalized Anxiety Disorder-7(GAD-7),Insomnia Severity Index(ISI),Somatic Symptom Scale-8(SSS-8),Sick,Control,One,Fat and Food(SCOFF),Perceived Stress Scale(PSS-10),and Brief Version of the Difficulties in Emotion Regulation Scale(DERS-16)to evaluate quality of life,depressive,anxiety,insomnia severity,somatic symptoms,eating disorders,stress perception,and emotion regulation abilities,respectively.A self-made self-injury risk screening questionnaire was used to screen self-harm thoughts and behaviors.Results:In the sample,the rates of college students with SF-12 mental and physical quality of life scores below 50 were 81.7%and 47.8%,respectively.Multiple linear regression analysis showed that there was a positive association between family per capita monthly income and SF-12 mental quality of life scores(β=0.04,P<0.05),while PSS-10(β=-0.27,P<0.001),PHQ-9(β=-0.25,P<0.001),DERS-16(β=-0.23,P<0.001),and GAD-7(β=-0.11,P<0.001)scores were negatively associated with SF-12 mental quality of life scores.The SSS-8 scores were negatively associated with SF-12 physical quality of life scores(β=-0.45,P<0.001).Conclusion:The study shows that a higher percentage of college students have a lower quality of life;the higher the levels of perceived stress,depression,emotional regulation difficulties,and anxiety,the lower the mental quality of life,and the more severe the physical discomfort symptoms,the lower the physical quality of life.

Result Analysis
Print
Save
E-mail